vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and HBT Financial, Inc. (HBT). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $67.3M, roughly 1.8× HBT Financial, Inc.). HBT Financial, Inc. runs the higher net margin — 16.6% vs 4.2%, a 12.4% gap on every dollar of revenue. Over the past eight quarters, HBT Financial, Inc.'s revenue compounded faster (9.0% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

HBT Financial, Inc. is a U.S.-headquartered regional bank holding company based in Illinois. It offers a full range of retail and commercial banking services including deposit accounts, consumer and business loan products, wealth management advisory, and mortgage services, primarily serving local community residents and small to mid-sized enterprise clients in its operating areas.

CLB vs HBT — Head-to-Head

Bigger by revenue
CLB
CLB
1.8× larger
CLB
$121.8M
$67.3M
HBT
Higher net margin
HBT
HBT
12.4% more per $
HBT
16.6%
4.2%
CLB
Faster 2-yr revenue CAGR
HBT
HBT
Annualised
HBT
9.0%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
HBT
HBT
Revenue
$121.8M
$67.3M
Net Profit
$5.1M
$11.2M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
16.6%
Revenue YoY
-1.4%
Net Profit YoY
-41.3%
EPS (diluted)
$0.11
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
HBT
HBT
Q1 26
$121.8M
$67.3M
Q4 25
$138.3M
$60.4M
Q3 25
$134.5M
$59.8M
Q2 25
$130.2M
$58.8M
Q1 25
$123.6M
$58.0M
Q4 24
$129.2M
$59.0M
Q3 24
$134.4M
$56.4M
Q2 24
$130.6M
$56.6M
Net Profit
CLB
CLB
HBT
HBT
Q1 26
$5.1M
$11.2M
Q4 25
$4.9M
Q3 25
$14.2M
$19.8M
Q2 25
$10.6M
$19.2M
Q1 25
$-154.0K
$19.1M
Q4 24
$7.4M
$20.3M
Q3 24
$11.7M
$18.2M
Q2 24
$9.0M
$18.1M
Gross Margin
CLB
CLB
HBT
HBT
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
HBT
HBT
Q1 26
1.5%
Q4 25
11.5%
42.9%
Q3 25
15.6%
44.7%
Q2 25
11.7%
44.8%
Q1 25
3.6%
44.0%
Q4 24
11.0%
46.4%
Q3 24
14.7%
43.4%
Q2 24
12.3%
44.1%
Net Margin
CLB
CLB
HBT
HBT
Q1 26
4.2%
16.6%
Q4 25
3.6%
Q3 25
10.6%
33.0%
Q2 25
8.2%
32.7%
Q1 25
-0.1%
32.9%
Q4 24
5.7%
42.8%
Q3 24
8.7%
32.2%
Q2 24
6.9%
31.9%
EPS (diluted)
CLB
CLB
HBT
HBT
Q1 26
$0.11
$0.34
Q4 25
$0.11
$0.60
Q3 25
$0.30
$0.63
Q2 25
$0.22
$0.61
Q1 25
$0.00
$0.60
Q4 24
$0.15
$0.64
Q3 24
$0.25
$0.57
Q2 24
$0.19
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
HBT
HBT
Cash + ST InvestmentsLiquidity on hand
$22.8M
$287.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$747.4M
Total Assets
$587.7M
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
HBT
HBT
Q1 26
$22.8M
$287.7M
Q4 25
$22.7M
$122.3M
Q3 25
$25.6M
$155.1M
Q2 25
$31.2M
$195.7M
Q1 25
$22.1M
$211.6M
Q4 24
$19.2M
$137.7M
Q3 24
$21.5M
$179.7M
Q2 24
$17.7M
$195.2M
Total Debt
CLB
CLB
HBT
HBT
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
HBT
HBT
Q1 26
$275.1M
$747.4M
Q4 25
$266.0M
$615.5M
Q3 25
$271.3M
$599.1M
Q2 25
$261.3M
$580.9M
Q1 25
$253.4M
$565.1M
Q4 24
$246.6M
$544.6M
Q3 24
$250.7M
$537.7M
Q2 24
$240.3M
$509.5M
Total Assets
CLB
CLB
HBT
HBT
Q1 26
$587.7M
$6.8B
Q4 25
$584.0M
$5.1B
Q3 25
$591.4M
$5.0B
Q2 25
$602.1M
$5.0B
Q1 25
$591.5M
$5.1B
Q4 24
$585.1M
$5.0B
Q3 24
$600.5M
$5.0B
Q2 24
$597.8M
$5.0B
Debt / Equity
CLB
CLB
HBT
HBT
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
HBT
HBT
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
HBT
HBT
Q1 26
$4.0M
Q4 25
$7.9M
$85.1M
Q3 25
$8.5M
$17.2M
Q2 25
$13.9M
$13.6M
Q1 25
$6.7M
$30.4M
Q4 24
$20.6M
$89.4M
Q3 24
$13.1M
$25.5M
Q2 24
$17.1M
$19.8M
Free Cash Flow
CLB
CLB
HBT
HBT
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
HBT
HBT
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
HBT
HBT
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
HBT
HBT
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
0.87×
Q2 25
1.31×
0.70×
Q1 25
1.60×
Q4 24
2.78×
4.41×
Q3 24
1.12×
1.40×
Q2 24
1.90×
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

HBT
HBT

Net Interest Income$56.4M84%
Noninterest Income$10.9M16%

Related Comparisons